Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Improved Sensitivity in Detection of FMS-like Tyrosine Kinase Internal Tandem Duplication of a Method Using Next-Generation Sequencing Data

Junghoon Shin, MD, Daeyoon Kim, MS, Yoojin Hong, Youngil Koh, MD PhD, Hongseok Yun, Dong-Yeop Shin, MD PhD, Sung-Soo Yoon, MD PhD, Inho Kim, Junglim Lee, MD, Byung-Su Kim, MD PhD

Blood (2016) 128 (22): 2844.

https://doi.org/10.1182/blood.V128.22.2844.2844

Published: 2016

Journal Articles

Anti-Leukemic Activation of Immune Cells in a Leukemic-Induced Microenvironment By CXCR4 Inhibition

Heeje Kim, A-Reum Han, Ji Yoon Lee, Woo-Sung Min, Gyeongsin Park, Se-Hoon Kim, Junglim Lee, MD

Blood (2015) 126 (23): 2539.

https://doi.org/10.1182/blood.V126.23.2539.2539

Published: 2015

Journal Articles

Genetic Profile and Novel Thrombospondin-1(THBS1) Mutation of Familial AML Syndrome: A Genomic Analysis By Whole Genome Sequencing and Whole Transcriptome Sequencing

Daeyoon Kim, Youngil Koh, MD, Jeonghwan Youk, Kwang-Sung Ahn, PhD, Hwi-Joong Yoon, MD, PhD, Hyun Jung Lee, MD, Hyo Jung Kim, MD PhD, Junglim Lee, MD, Sung-Soo Yoon, MDPhD

Blood (2015) 126 (23): 2595.

https://doi.org/10.1182/blood.V126.23.2595.2595

Published: 2015

Journal Articles

IL-6 Released from BMSCs Suppresses Cytotoxic Effect of Ara-C and IL-6 Mediated Signaling Enhances Re-Growing of HEL Cells Following Ara-C Treatment

Hyejoo Park, Daeyoon Kim, Chansu Lee, PhD, Eunkyung Bae, PhD, Kwang-Sung Ahn, PhD, Youngil Koh, MD, Hyun Jung Lee, MD, Hyo Jung Kim, MD, Junglim Lee, MD, Hwi-Joong Yoon, MDPhD, Sung-Soo Yoon, MDPhD

Blood (2015) 126 (23): 4962.

https://doi.org/10.1182/blood.V126.23.4962.4962

Published: 2015

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Je-Hwan Lee, MD PhD, Hawk Kim, MD PhD, Young-Don Joo, MD, Won Sik Lee, Sung Hwa Bae, MD, Dae Young Zang, Jihyun Kwon, MD, Min Kyoung Kim, Junglim Lee, MD, Gyeong Won Lee, Jung-Hee Lee, MD PhD, Yunsuk Choi, MD PhD, Dae-Young Kim, MD PhD, Sung-Nam Lim, MD, Sang-Min Lee, Hun-Mo Ryoo, MD, Hyo Jung Kim, Myung Soo Hyun, Kyoo-Hyung Lee, MD PhD

Blood (2015) 126 (23): 2535.

https://doi.org/10.1182/blood.V126.23.2535.2535

Published: 2015

Journal Articles

Defining Parameters That Can Guide Public Cord Blood Units (CBUs) in Korea

Junglim Lee, MD, Byung-Su Kim, MD, Soon- Hi Jang, MDPhD, Tai-Gyu KIM, MDPhD

Blood (2015) 126 (23): 3102.

https://doi.org/10.1182/blood.V126.23.3102.3102

Published: 2015

Journal Articles

Factors Affecting Clinical Outcomes after CLAG/CLAG-M Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia

Hyunkyung Park, MD, Jeonghwan Youk, MD, Youngil Koh, MD, Inho Kim, MD PhD, Seonyang Park, MD PhD, Jeong-Ok Lee, Soo-Mee Bang, Hyo Jung Kim, MD PhD, Hwi-Joong Yoon, MD PhD, Junglim Lee, MD, Sung-Soo Yoon, MD PhD

Blood (2014) 124 (21): 5289.

https://doi.org/10.1182/blood.V124.21.5289.5289

Published: 2014

Journal Articles

Everolimus in Combination with Crizotinib Synergistically Inhibits the Growth of ALK-Positive Anaplastic Large Cell Lymphoma Cells

Wendan Xu, MS, Ji-Won Kim, MD MS, Junglim Lee, MD, Hyo Jung Kim, MD PhD, Hwi-Joong Yoon, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2014) 124 (21): 4488.

https://doi.org/10.1182/blood.V124.21.4488.4488

Published: 2014

Journal Articles

Mutation in Retinoic X Receptor-γ Is a Possible Mechanism of All-Trans Retinoic Acid Resistance in Acute Promyelocytic Leukemia(APL): Identifying Genetic Changes Related to Drug Resistance in APL Using Whole Exome Sequencing

Jeonghwan Youk, MD, Youngil Koh, MD, Hyunkyung Park, Dae-Yoon Kim, Chan-Soo Lee, Junglim Lee, MD, Hyo Jung Kim, MD PhD, Hwi-Joong Yoon, MD PhD, Kwang-Sung Ahn, PhD, Jong-Sun Jung, PhD, Inho Kim, MD PhD, Seonyang Park, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2014) 124 (21): 2358.

https://doi.org/10.1182/blood.V124.21.2358.2358

Published: 2014

Journal Articles

Defining Parameters That Can Guide Public Cord Blood Units (CBUs) In Korea

Junglim Lee, MD

Blood (2013) 122 (21): 3277.

https://doi.org/10.1182/blood.V122.21.3277.3277

Published: 2013

Journal Articles

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Mark H. Lee, MD., PhD., Sung-Yong Kim, MD.PhD., Inho Kim, MD, PhD, Seonyang Park, MD, PhD, Yeo-Kyeoung Kim, MD.PhD., Yang Soo Kim, MD.PhD., Ho Sup Lee, MD, Jeong-A Kim, MD.PhD., Jinny Park, MD.PhD., Seok Jin Kim, MD, PhD, Sung Kyu Park, MD.PhD., Byeong-Bae Park, MD.PhD., Hyeok Shim, MD.PhD., Hyeon Seok Eom, MD, Junglim Lee, MD

Blood (2012) 120 (21): 4517.

https://doi.org/10.1182/blood.V120.21.4517.4517

Published: 2012

Journal Articles

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Blood (2010) 116 (21): 1707.

https://doi.org/10.1182/blood.V116.21.1707.1707

Published: 2010

Journal Articles

Preliminary Results of a Prospective Multicenter Phase III Trial Comparing High-Dose and Standard-Dose Daunorubicin for Induction of Complete Remission (CR) in Acute Myeloid Leukemia (AML).

Blood (2007) 110 (11): 1833.

https://doi.org/10.1182/blood.V110.11.1833.1833

Published: 2007

NARROW

Improved Sensitivity in Detection of FMS-like Tyrosine Kinase Internal Tandem Duplication of a Method Using Next-Generation Sequencing Data

Anti-Leukemic Activation of Immune Cells in a Leukemic-Induced Microenvironment By CXCR4 Inhibition

Genetic Profile and Novel Thrombospondin-1(THBS1) Mutation of Familial AML Syndrome: A Genomic Analysis By Whole Genome Sequencing and Whole Transcriptome Sequencing

IL-6 Released from BMSCs Suppresses Cytotoxic Effect of Ara-C and IL-6 Mediated Signaling Enhances Re-Growing of HEL Cells Following Ara-C Treatment

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Defining Parameters That Can Guide Public Cord Blood Units (CBUs) in Korea

Factors Affecting Clinical Outcomes after CLAG/CLAG-M Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia

Everolimus in Combination with Crizotinib Synergistically Inhibits the Growth of ALK-Positive Anaplastic Large Cell Lymphoma Cells

Mutation in Retinoic X Receptor-γ Is a Possible Mechanism of All-Trans Retinoic Acid Resistance in Acute Promyelocytic Leukemia(APL): Identifying Genetic Changes Related to Drug Resistance in APL Using Whole Exome Sequencing

Defining Parameters That Can Guide Public Cord Blood Units (CBUs) In Korea

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Preliminary Results of a Prospective Multicenter Phase III Trial Comparing High-Dose and Standard-Dose Daunorubicin for Induction of Complete Remission (CR) in Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only